Follow the people · Insider
Joseph Walter Vazzano
Joseph Walter Vazzano files insider transactions with the SEC as a chief financial officer of Abeona Therapeutics (ABEO). We hold 6 disclosed purchases and sales filed since 28 June 2018, 2 of them in the last 90 days.
- Files forABEO
- Disclosed buys and sells6 in all, 2 in the last 90 days
- Last disclosure22 July 2026
Positions held
3 posts we hold — a term names its own dates; a run of filings only says when they filed- Filed 14 March 2022 — 21 July 2026Chief Financial Officer · Abeona Therapeutics (ABEO)35 Form 4 lines · source: SEC Form 4
- Filed 22 January 2025 — 22 January 2025Director · Allarity Therapeutics (ALLR)2 Form 4 lines · source: SEC Form 4
- Filed 28 June 2018 — 17 December 2021Chief Financial Officer · Avenue Therapeutics (ATXI)13 Form 4 lines · source: SEC Form 4
Everything they disclosed
50 entries, newest first — one per disclosure report, one per Form 4 line- ▼ sold on the open market 1,478 shares of Abeona TherapeuticsSEC Form 422 July 2026Common Stock · traded 21 July 2026 · filed 22 July 2026
- ▼ sold on the open market 24,880 shares of Abeona TherapeuticsSEC Form 49 July 2026Common Stock · traded 9 July 2026 · filed 9 July 2026
- ▼ sold on the open market 10,271 shares of Abeona TherapeuticsSEC Form 49 June 2026Common Stock · traded 8 June 2026 · filed 9 June 2026
- ▼ sold on the open market 13,421 shares of Abeona TherapeuticsSEC Form 49 June 2026Common Stock · traded 9 June 2026 · filed 9 June 2026
- ▼ sold on the open market 25,646 shares of Abeona TherapeuticsSEC Form 49 June 2026Common Stock · traded 9 June 2026 · filed 9 June 2026
- ▼ sold on the open market 785 shares of Abeona TherapeuticsSEC Form 416 March 2026Common Stock · traded 16 March 2026 · filed 16 March 2026
- ▼ sold on the open market 785 shares of Abeona TherapeuticsSEC Form 416 March 2026Common Stock · traded 16 March 2026 · filed 16 March 2026
- ▼ sold on the open market 18,666 shares of Abeona TherapeuticsSEC Form 422 January 2026Common Stock · traded 22 January 2026 · filed 22 January 2026
- ▼ sold on the open market 18,666 shares of Abeona TherapeuticsSEC Form 422 January 2026Common Stock · traded 22 January 2026 · filed 22 January 2026
- was granted 133,595 shares of Abeona TherapeuticsSEC Form 420 January 2026Common Stock · traded 20 January 2026 · filed 20 January 2026
- was granted 133,595 shares of Abeona TherapeuticsSEC Form 420 January 2026Common Stock · traded 20 January 2026 · filed 20 January 2026
- ▼ sold on the open market 9,035 shares of Abeona TherapeuticsSEC Form 41 October 2025Common Stock · traded 29 September 2025 · filed 1 October 2025
- ▼ sold on the open market 15,000 shares of Abeona TherapeuticsSEC Form 415 August 2025Common Stock · traded 15 August 2025 · filed 15 August 2025
- ▼ sold on the open market 1,502 shares of Abeona TherapeuticsSEC Form 422 July 2025Common Stock · traded 22 July 2025 · filed 22 July 2025
- ▼ sold on the open market 25,411 shares of Abeona TherapeuticsSEC Form 410 July 2025Common Stock · traded 9 July 2025 · filed 10 July 2025
- was granted 13,333 shares of Abeona TherapeuticsSEC Form 49 June 2025Common Stock · traded 5 June 2025 · filed 9 June 2025
- ▼ sold on the open market 17,795 shares of Abeona TherapeuticsSEC Form 46 June 2025Common Stock · traded 6 June 2025 · filed 6 June 2025
- had shares withheld for tax on 685 shares of Abeona TherapeuticsSEC Form 417 March 2025Common stock · traded 14 March 2025 · filed 17 March 2025
- was granted 25,000 shares of Allarity Therapeutics (a derivative holding)SEC Form 424 January 2025Stock Options · traded 22 January 2025 · filed 24 January 2025
- was granted 25,000 shares of Allarity Therapeutics (a derivative holding)SEC Form 424 January 2025Stock Options · traded 22 January 2025 · filed 24 January 2025
- was granted 144,509 shares of Abeona TherapeuticsSEC Form 423 January 2025Common stock · traded 21 January 2025 · filed 23 January 2025
- had shares withheld for tax on 6,388 shares of Abeona TherapeuticsSEC Form 430 September 2024Common stock · traded 28 September 2024 · filed 30 September 2024
- had shares withheld for tax on 1,055 shares of Abeona TherapeuticsSEC Form 422 July 2024Common stock · traded 21 July 2024 · filed 22 July 2024
- was granted 155,200 shares of Abeona TherapeuticsSEC Form 49 July 2024Common stock · traded 8 July 2024 · filed 9 July 2024
- had shares withheld for tax on 16,408 shares of Abeona TherapeuticsSEC Form 47 June 2024Common stock · traded 5 June 2024 · filed 7 June 2024
- ▲ bought on the open market 5,608 shares of Abeona TherapeuticsSEC Form 426 April 2024Common stock · traded 25 April 2024 · filed 26 April 2024
- had shares withheld for tax on 703 shares of Abeona TherapeuticsSEC Form 415 March 2024Common stock · traded 15 March 2024 · filed 15 March 2024
- had shares withheld for tax on 6,230 shares of Abeona TherapeuticsSEC Form 429 September 2023Common stock · traded 29 September 2023 · filed 29 September 2023
- ▲ bought on the open market 14 shares of Abeona TherapeuticsSEC Form 420 September 2023Common stock · traded 19 September 2023 · filed 20 September 2023
- ▲ bought on the open market 2,986 shares of Abeona TherapeuticsSEC Form 420 September 2023Common stock · traded 19 September 2023 · filed 20 September 2023
- had shares withheld for tax on 1,187 shares of Abeona TherapeuticsSEC Form 425 July 2023Common stock · traded 24 July 2023 · filed 25 July 2023
- was granted 141,908 shares of Abeona TherapeuticsSEC Form 47 June 2023Common stock · traded 5 June 2023 · filed 7 June 2023
- had shares withheld for tax on 792 shares of Abeona TherapeuticsSEC Form 417 March 2023Common stock · traded 15 March 2023 · filed 17 March 2023
- ▲ bought on the open market 2,500 shares of Abeona TherapeuticsSEC Form 421 November 2022Common stock · traded 18 November 2022 · filed 21 November 2022
- was granted 72,750 shares of Abeona TherapeuticsSEC Form 430 September 2022Common stock · traded 28 September 2022 · filed 30 September 2022
- was granted 12,000 shares of ABEOSEC Form 425 July 2022Common stock · traded 21 July 2022 · filed 25 July 2022
- was granted 200,000 shares of Abeona TherapeuticsSEC Form 416 March 2022Common stock · traded 14 March 2022 · filed 16 March 2022
- was granted 100,505 shares of Avenue TherapeuticsSEC Form 420 December 2021Common Stock · traded 17 December 2021 · filed 20 December 2021
- ▼ sold on the open market 7,160 shares of Avenue TherapeuticsSEC Form 415 September 2021Common Stock · traded 15 September 2021 · filed 15 September 2021
- ▼ sold on the open market 3,840 shares of Avenue TherapeuticsSEC Form 421 August 2020Common Stock · traded 20 August 2020 · filed 21 August 2020
- ▲ bought on the open market 1,400 shares of Avenue TherapeuticsSEC Form 410 March 2020Common Stock · traded 9 March 2020 · filed 10 March 2020
- ▲ bought on the open market 100 shares of Avenue TherapeuticsSEC Form 410 March 2020Common Stock · traded 9 March 2020 · filed 10 March 2020
- ▲ bought on the open market 1,889 shares of Avenue TherapeuticsSEC Form 410 March 2020Common Stock · traded 10 March 2020 · filed 10 March 2020
- ▲ bought on the open market 1,200 shares of Avenue TherapeuticsSEC Form 425 February 2020Common Stock · traded 25 February 2020 · filed 25 February 2020
- was granted 22,727 shares of Avenue Therapeutics (a derivative holding)SEC Form 413 February 2020Restricted Stock Units · traded 12 February 2020 · filed 13 February 2020
- ▼ sold on the open market 2,313 shares of Avenue TherapeuticsSEC Form 412 August 2019Common Stock · traded 8 August 2019 · filed 12 August 2019
- ▼ sold on the open market 2,375 shares of Avenue TherapeuticsSEC Form 412 August 2019Common Stock · traded 9 August 2019 · filed 12 August 2019
- was granted 27,778 shares of Avenue Therapeutics (a derivative holding)SEC Form 45 June 2019Restricted Stock Units · traded 3 June 2019 · filed 5 June 2019
- gave away 30,000 shares of Avenue TherapeuticsSEC Form 48 August 2018Common Stock · traded 7 August 2018 · filed 8 August 2018
- was granted 1,351 shares of Avenue TherapeuticsSEC Form 428 June 2018Common Stock · traded 28 June 2018 · filed 28 June 2018
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.